1. Home
  2. EBS vs VACH Comparison

EBS vs VACH Comparison

Compare EBS & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • VACH
  • Stock Information
  • Founded
  • EBS 1998
  • VACH 2023
  • Country
  • EBS United States
  • VACH United States
  • Employees
  • EBS 900
  • VACH N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • VACH
  • Sector
  • EBS Health Care
  • VACH
  • Exchange
  • EBS Nasdaq
  • VACH NYSE
  • Market Cap
  • EBS 353.9M
  • VACH 324.2M
  • IPO Year
  • EBS 2006
  • VACH 2024
  • Fundamental
  • Price
  • EBS $6.39
  • VACH $10.39
  • Analyst Decision
  • EBS Strong Buy
  • VACH
  • Analyst Count
  • EBS 3
  • VACH 0
  • Target Price
  • EBS $14.33
  • VACH N/A
  • AVG Volume (30 Days)
  • EBS 1.3M
  • VACH 108.5K
  • Earning Date
  • EBS 08-05-2025
  • VACH 01-01-0001
  • Dividend Yield
  • EBS N/A
  • VACH N/A
  • EPS Growth
  • EBS N/A
  • VACH N/A
  • EPS
  • EBS N/A
  • VACH 0.30
  • Revenue
  • EBS $965,400,000.00
  • VACH N/A
  • Revenue This Year
  • EBS N/A
  • VACH N/A
  • Revenue Next Year
  • EBS $18.88
  • VACH N/A
  • P/E Ratio
  • EBS N/A
  • VACH $35.18
  • Revenue Growth
  • EBS N/A
  • VACH N/A
  • 52 Week Low
  • EBS $4.02
  • VACH $9.95
  • 52 Week High
  • EBS $15.10
  • VACH $11.20
  • Technical
  • Relative Strength Index (RSI)
  • EBS 60.32
  • VACH N/A
  • Support Level
  • EBS $6.53
  • VACH N/A
  • Resistance Level
  • EBS $6.98
  • VACH N/A
  • Average True Range (ATR)
  • EBS 0.35
  • VACH 0.00
  • MACD
  • EBS 0.01
  • VACH 0.00
  • Stochastic Oscillator
  • EBS 84.04
  • VACH 0.00

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About VACH VOYAGER ACQUISITION CORP.

Voyager Acquisition Corp is a blank check company.

Share on Social Networks: